Dieter Saur is a physician scientist and Professor of the German Cancer Consortium (DKTK). He heads the Division of Translational Cancer Research at the German Cancer Research Center (DKFZ) and is the Director of the Institute of Experimental Cancer Therapy at the TUM School of Medicine (https://www.translatum.tum.de/). His group studies fundamental biologically and clinically relevant aspects of pancreatic cancer: how it develops, progresses, spreads to distant sites, and why it becomes resistant to anti-cancer therapies. Over the last 20 years, his lab has generated unique biological resources and genetic tools to analyze the therapeutic response of cancer subtypes in vitro and in predictive immunocompetent in vivo models. Thereby, the lab explores new ways to target solid tumors more efficiently and to translate these finding to clinical trials to improve the prognosis of pancreatic cancer patients. Saur has published >190 papers and received an ERC Consolidator Grant and the German Cancer Award for his work in pancreatic cancer.